Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical models.
Journal: Science advances
Published: June 18, 2025
Creation of a Peptide Antagonist of the GFRAL-RET Receptor Complex for the Treatment of GDF15-Induced Malaise.
Journal: Journal of medicinal chemistry
Published: July 28, 2023
GIP receptor agonism blocks chemotherapy-induced nausea and vomiting.
Journal: Molecular metabolism
Published: March 10, 2023
Peripherally restricted oxytocin is sufficient to reduce food intake and motivation, while CNS entry is required for locomotor and taste avoidance effects.
Journal: Diabetes, obesity & metabolism
Published: August 17, 2022
Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons.
Journal: Molecular metabolism
Published: December 08, 2021
Synthesis, Optimization, and Biological Evaluation of Corrinated Conjugates of the GLP-1R Agonist Exendin-4.
Journal: Journal of medicinal chemistry
Published: March 08, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026